All Topics

Early determination, sanctions, confidentiality, costs and settlements concluded without authority amongst topics addressed in 8 recent first-instance decisions handed down over 3-month period.

This briefing note sets out a detailed overview of the Restricting Non-disclosure Agreements (Sexual Harassment at Work) Act 2025 (Vic) (the Act), which commences on 1 July 2026.

A Paris roundtable examined China's transformation into a biotechnology powerhouse and the strategic opportunities this creates for European life sciences companies and investors. Industry leaders discussed how to structure cross-border partnerships that leverage Chinese innovation and development speed while navigating intellectual property protection, regulatory frameworks, and evolving geopolitical considerations.